Bedossa P

Idioma: Ingles.
Referencias bibliográficas: 7
Paginas: 450-451
Archivo PDF: 113.20 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Nime F, Pickren JW, Vana J, Aronoff BL, Baker HW, Murphy GP. The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer. Cancer 1979; 44: 1481-9.

2. Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006; 43: 515-24

3. Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, Laurent C, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009; 50: 481-9.

4. Bluteau O, Jeannot E, Bioulac-Sage P, Marqués JM, Blanc JF, Bui H, Beaudoin JC, et al. Bi-allellic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002; 32: 312-5.

5. Paradis V1, Champault A, Ronot M, Deschamps L, Valla DC, Vidaud D, Vilgrain V, et al. Telangiectatic adenomas: an entity associated with increased body mass index and inflammation. Hepatology 2007; 46:140-6.

6. Rebouissou S1, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, Izard T, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumors. Nature 2009; 457: 2000-4.

7. Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009; 137: 1698-705.